About News News Subscribe Economics Health Policy Facet Area of Focus - News Ian H. Solomon Craig Volden Brian N. Williams Christine Mahoney Kirsten Gelsdorf Benjamin Castleman Gerald Warburg Gabrielle Adams Jay Shimshack John Holbein Lucy Bassett Philip Potter Daphna Bassok David Leblang Andrew S. Pennock Allan Stam Raymond C. Scheppach Sarah Turner Sophie Trawalter Timothy L. Davis Bala Mulloth Benjamin Converse Eileen Chou Jeanine Braithwaite Jennifer Lawless Jill Rockwell Sebastian Tello-Trillo Todd S. Sechser James H. Wyckoff Paul S. Martin Peter Johannessen Steve Hiss Laura Toscano Michael D. Williams Noah Myung William Shobe Brooke Lehmann Daniel W. Player Gerard Robinson Harry Harding James R. Detert Jeff Chidester Larry Terry Margaret Foster Riley Molly Lipscomb Abigail Scholer Adam Leive Allison Atteberry Brad Carson Frederick P. Hitz Galen Fountain Isaac Mbiti Jazmin Brown-Iannuzzi Michele Claibourn Sally Hudson Xiao Wang Adam Roux Alexander Bick Amanda Crombie Andy Ortiz Brendan J. Boler Brooke Ray Charles J. Rush Charles J. Rush Derek Wu Diane Biesecker George Foresman Gerald Higginbotham Jieun Pai Justin H. Kirkland Kimberly Jenkins Robinson Kyle S. H. Dobson Melissa Thomas-Hunt Pam Cipriano Paul Becker Xiao Wang (-) Christopher J. Ruhm Facet People - News Facet UVA Partner - News Research and Commentary Faculty In Action Facet News Type - News Dec 13, 2023 Ruhm Named SEA Distinguished Fellow Chris Ruhm, Batten professor of public policy and economics, has received a Distinguished Fellow Award from the Southern Economic Association in recognition for his “substantial record of exceptional scholarly achievement and long-term involvement and service to the association.” Learn more Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY Stay Up To Date with the Latest Batten News and Events Subscribe
Dec 13, 2023 Ruhm Named SEA Distinguished Fellow Chris Ruhm, Batten professor of public policy and economics, has received a Distinguished Fellow Award from the Southern Economic Association in recognition for his “substantial record of exceptional scholarly achievement and long-term involvement and service to the association.” Learn more
Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more
May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill
May 03, 2021 Federal Opioid Grant Funding Favors Least Populous States, Not Those With the Greatest Need Economics Health Policy In a new paper published in the journal Health Affairs, Batten’s Christopher J. Ruhm and co-author Bradley A. Katcher find that the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. Learn more
Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more
Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY